Save time and get answers to complex questions with AI chat
Motegrity ingredients?Drugpatentwatch crizotinib?What's the advised delay for milk post lipitor?Drug patent watch trametinib?Drugpatentwatch market analysis industry today?
See the DrugPatentWatch profile for Gemtesa
Gemtesa is the brand name for vibegron, a beta-3 adrenergic receptor agonist used to treat overactive bladder (OAB) in adults. What it does - Helps reduce urinary urgency, frequency, and urge incontinence by relaxing the bladder detrusor muscle to increase bladder storage capacity. How it’s taken - Usually 75 mg once daily by mouth, with or without food. Do not crush or chew the tablet. Common side effects - Urinary tract infection - Nasopharyngitis (common cold symptoms) - Headache - Other rare side effects can occur; talk to a clinician if you notice anything concerning. Who shouldn’t use it or needs caution - As with all medicines, discuss with your doctor if you have liver or kidney problems, are pregnant or breastfeeding, or are taking other prescription or over-the-counter drugs that could interact. - Your clinician can advise about safety in your specific health situation and whether Gemtesa is appropriate for you. If you’d like, I can share more detailed prescribing information or help compare Gemtesa to other OAB treatments.
Other Questions About Gemtesa :